Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3,930 JPY | -0.63% | -0.76% | +10.55% |
Feb. 13 | LIM Advisors Partially Withdraws Shareholder Proposal | CI |
Feb. 09 | Torii Pharmaceuticals Opposes Shareholder Proposal | CI |
Sales 2024 * | 57.8B 369M | Sales 2025 * | 61.22B 391M | Capitalization | 110B 705M |
---|---|---|---|---|---|
Net income 2024 * | 4.88B 31.22M | Net income 2025 * | 5.65B 36.12M | EV / Sales 2024 * | 1.91 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 1.8 x |
P/E ratio 2024 * |
22.6
x | P/E ratio 2025 * |
19.5
x | Employees | 583 |
Yield 2024 * |
3.05% | Yield 2025 * |
3.05% | Free-Float | 42.14% |
1 day | -0.63% | ||
1 week | -0.76% | ||
Current month | -0.38% | ||
1 month | -0.51% | ||
3 months | -1.13% | ||
6 months | +9.47% | ||
Current year | +10.55% |
Managers | Title | Age | Since |
---|---|---|---|
Goichi Matsuda
PSD | President | 57 | 17-02-28 |
Director of Finance/CFO | - | - | |
Megumi Kajiwara
CTO | Chief Tech/Sci/R&D Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Corporate Officer/Principal | 60 | 87-03-31 | |
Masao Torikai
BRD | Director/Board Member | 61 | 10-05-31 |
Masaki Sunami
PRN | Corporate Officer/Principal | 65 | 14-03-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.12% | 19 M€ | +11.67% | ||
0.05% | 2 M€ | -.--% | ||
0.02% | 7 M€ | -.--% | - | |
0.01% | 17 M€ | +15.35% | - | |
0.01% | 20,360 M€ | +15.38% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-14 | 3,930 | -0.63% | 18 500 |
24-05-13 | 3,955 | -1.49% | 10,100 |
24-05-10 | 4,015 | -0.50% | 19,400 |
24-05-09 | 4,035 | +1.51% | 8,200 |
24-05-08 | 3,975 | -0.25% | 22,900 |
Delayed Quote Japan Exchange, May 14, 2024 at 02:00 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+10.55% | 711M | |
+31.06% | 682B | |
+30.35% | 586B | |
-3.42% | 364B | |
+18.02% | 327B | |
+4.27% | 285B | |
+15.53% | 240B | |
+10.16% | 209B | |
-8.14% | 203B | |
+8.12% | 165B |
- Stock Market
- Equities
- 4551 Stock